指南与共识复苏、休克与脓毒症重症综合管理与镇静镇痛儿科与产科急症

2021年重症患者血管内容量填充静脉液体选择指南

Guidelines for the choice of intravenous fluids for vascular filling in critically ill patients, 2021.
指南 / 共识 · Anaesth Crit Care Pain Med · 2022-05-05
一句话结论法国SFAR/SFMU指南就脓毒症、失血性休克、急性脑衰竭及围产期四类重症患者的复苏液体选择给出9条推荐,其中2条高证据等级、6条中等、1条专家意见。

该指南由法国麻醉与重症医学学会(SFAR)和法国急诊医学学会(SFMU)的24名专家组成的共识委员会制定,采用GRADE方法学,就脓毒症或脓毒性休克、失血性休克、急性脑衰竭和围产期四个领域的液体选择提出推荐。委员会围绕两个问题:与晶体液相比,胶体液是否降低发病率和死亡率;某些特定晶体液是否有效降低发病率和死亡率。最终形成9条推荐,经两轮评级和修订后全部达成强烈共识(100%),其中2条为高证据等级(Grade 1 +/-),6条为中等证据等级(Grade 2 +/-),1条基于专家意见,另有2个问题未形成推荐。

要点

  • 指南覆盖四类重症患者:脓毒症或脓毒性休克、失血性休克、急性脑衰竭、围产期。
  • 所有9条推荐经两轮评级和修订后达成100%强烈共识。
  • 证据等级分布:2条为高证据等级(Grade 1 +/-),6条为中等证据等级(Grade 2 +/-),1条基于专家意见。
  • 共有2个问题未形成推荐。
  • 指南制定过程独立于任何企业资助,并执行正式的利益冲突政策。

适用人群与场景

  • 脓毒症或脓毒性休克患者
  • 失血性休克患者
  • 急性脑衰竭患者
  • 围产期患者

研究设计与关键结果

  • 制定机构:法国麻醉与重症医学学会(SFAR)和法国急诊医学学会(SFMU)共识委员会,24名专家。
  • 方法:采用GRADE系统评估证据质量,部分推荐未分级。
  • 推荐数量:共9条关于重症患者复苏液体选择的推荐;经两轮评级和修订后,100%的推荐达成强烈共识。
  • 证据等级:2条高证据等级(Grade 1 +/-),6条中等证据等级(Grade 2 +/-),1条基于专家意见。
  • 有2个问题未形成推荐。

证据类型、等级与局限

  • 证据类型:指南/共识(SFAR/SFMU)。
  • 证据等级:2条Grade 1 +/-,6条Grade 2 +/-,1条专家意见;部分推荐未分级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

指南或共识出处

  • 指南名称:Guidelines for the choice of intravenous fluids for vascular filling in critically ill patients, 2021(2021年重症患者血管内容量填充静脉液体选择指南)。
  • 发布机构:法国麻醉与重症医学学会(SFAR)和法国急诊医学学会(SFMU)。
  • 年份:2021年。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To provide recommendations for the appropriate choice of fluid therapy for resuscitation of critically ill patients.

DESIGN: A consensus committee of 24 experts from the French Society of Anaesthesia and Intensive Care Medicine (Société française d'anesthésie et de réanimation, SFAR) and the French Society of Emergency Medicine (Société française de médecine d'urgence, SFMU) was convened. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. The entire guideline elaboration process was conducted independently of any industry funding. The authors were advised to follow the principles of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to guide their assessment of quality of evidence. The potential drawbacks of making strong recommendations in the presence of low-quality evidence were emphasised. Some recommendations were left ungraded.

METHODS: Four fields were defined: patients with sepsis or septic shock, patients with haemorrhagic shock, patients with acute brain failure, and patients during the peripartum period. For each field, the panel focused on two questions: (1) Does the use of colloids, as compared to crystalloids, reduce morbidity and mortality, and (2) Does the use of some specific crystalloids effectively reduce morbidity and mortality. Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. The analysis of the literature and the recommendations were then conducted according to the GRADE methodology.

RESULTS: The SFAR/SFMU guideline panel provided nine statements on the appropriate choice of fluid therapy for resuscitation of critically ill patients. After two rounds of rating and various amendments, strong agreement was reached for 100% of the recommendations. Out of these recommendations, two have a high level of evidence (Grade 1 +/-), six have a moderate level of evidence (Grade 2 +/-), and one is based on expert opinion. Finally, no recommendation was formulated for two questions.

CONCLUSIONS: Substantial agreement among experts has been obtained to provide a sizable number of recommendations aimed at optimising the choice of fluid therapy for resuscitation of critically ill patients.

来源:Anaesth Crit Care Pain Med,查看原文。版权归原作者所有。

参考来源

  1. Joannes-Boyau O, Le Conte P, Bonnet MP, et al. Guidelines for the choice of intravenous fluids for vascular filling in critically ill patients, 2021. Anaesth Crit Care Pain Med. 2022. PMID: 35526312. doi:10.1016/j.accpm.2022.101058

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。